These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3139576)

  • 21. Effect of immunostimulants and antitumor agents on tumor necrosis factor (TNF) production.
    Mori H; Mihara M; Teshima K; Uesugi U; Xu Q; Sakamoto O; Koda A
    Int J Immunopharmacol; 1987; 9(8):881-92. PubMed ID: 2448255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of immune responsiveness by a biological response modifier, PSK, in aged mice bearing syngeneic transplantable tumor.
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    J Clin Lab Immunol; 1987 Nov; 24(3):143-9. PubMed ID: 3430562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of PSK on the recovery of macrophage function in tumor-bearing mice].
    Ando T; Mastuda Y; Matsunaga K; Fujii T; Yoshikumi C; Nomoto K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):827-34. PubMed ID: 6721504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice.
    Matsunaga K; Morita I; Oguchi Y; Fujii T; Yoshikumi C; Nomoto K
    Anticancer Res; 1987; 7(3 Pt B):509-12. PubMed ID: 3631910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of PSK on prohibited immunity of splenectomized mice.
    Fujii T; Kano T; Saito K; Kobayashi Y; Iijima H; Matsumoto T; Yoshikumi C; Taguchi T
    Anticancer Res; 1987; 7(4B):845-8. PubMed ID: 3674771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical aspects of immunomodulation by Propionibacterium acnes.
    Hajdúch M; Weigl E; Jezdínská V; Zpĕvácková L
    Acta Univ Palacki Olomuc Fac Med; 1993; 136():9-12. PubMed ID: 7887204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Schistosoma mansoni infection on the hepatic drug-metabolizing capacity of mice.
    Cha YN; Edwards R
    J Pharmacol Exp Ther; 1976 Nov; 199(2):432-40. PubMed ID: 185361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of Propionibacterium acnes (Corynebacterium parvum) fractions on immune response in vivo.
    Mára M; Julák J; Bednár M; Ocenásková J; Miková Z; Dohnalová A
    Zentralbl Bakteriol; 1994 Nov; 281(4):549-55. PubMed ID: 7727904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal inoculation with the protein-bound polysaccharide PSK increases resistance of adult animals to challenge with syngeneic tumor cells and reduces azoxymethane-induced precancerous lesions in the colon.
    Matsunaga K; Iijima H; Kobayashi H
    Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1313-22. PubMed ID: 11142416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphological and biochemical alterations of macrophages produced by a glycan, PSK.
    Kamisato JK; Nowakowski M
    Immunopharmacology; 1988; 16(2):89-96. PubMed ID: 3204014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cord factor, a toxic glycolipid from Mycobacterium tuberculosis, on mouse liver drug metabolizing enzymes.
    Batra JK; Raj HG; Subramanian TA
    Toxicon; 1987; 25(3):345-9. PubMed ID: 3109076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competitive action of a biological response modifier, PSK, on a humoral immunosuppressive factor produced in tumor-bearing hosts.
    Matsunaga K; Morita I; Iijima H; Endo H; Oguchi Y; Yoshimura M; Fujii T; Yoshikumi C; Nomoto K
    J Clin Lab Immunol; 1990 Mar; 31(3):127-36. PubMed ID: 1966997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of Corynebacterium parvum, BCG, OK-432 and Lactobacillus casei on the hepatic drug-metabolizing systems and on the oxygen radical production by fixed macrophages in liver of BALB/c mouse].
    Hashimoto S; Yokokura T; Mutai M
    Yakugaku Zasshi; 1984 Apr; 104(4):356-61. PubMed ID: 6491874
    [No Abstract]   [Full Text] [Related]  

  • 34. PSK as a chemopreventive agent.
    Kobayashi H; Matsunaga K; Fujii M
    Cancer Epidemiol Biomarkers Prev; 1993; 2(3):271-6. PubMed ID: 8318880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antitumor effect of intratumoral administration of a Coriolus preparation, PSK: inhibition of tumor invasion in vitro].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2241-3. PubMed ID: 7944450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postmortem changes in drug-metabolizing enzymes of rat liver microsome.
    Yamazaki M; Wakasugi C
    Forensic Sci Int; 1994 Aug; 67(3):155-68. PubMed ID: 7959472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression of hepatic drug metabolism in endotoxin-treated and sarcoma-bearing mice.
    Bertini R; Gervasi PG; Longo V; Ghezzi P
    Res Commun Chem Pathol Pharmacol; 1992 May; 76(2):223-31. PubMed ID: 1604046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a mouse serum protein increased by administration of an antitumor polysaccharide, PSK, as a variant of mouse transferrin and some of its biological activities.
    Kojima E; Mitsuno T; Osawa T
    J Pharmacobiodyn; 1986 Feb; 9(2):174-81. PubMed ID: 3712215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic toxicity of cimetidine on hepatic and renal drug metabolism.
    Solangi KB; Lutton JD; Svogun JA; Ibraham NG; Goodman AI; Levere RD
    Res Commun Chem Pathol Pharmacol; 1984 Jul; 45(1):19-35. PubMed ID: 6548043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zinc mediates normalization of hepatic drug metabolizing enzymes in chlorpyrifos-induced toxicity.
    Goel A; Dani V; Dhawan DK
    Toxicol Lett; 2007 Feb; 169(1):26-33. PubMed ID: 17194553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.